ARTICLE SYNOPSIS...Pfizer has been underperforming for many years. But now there are signs the stock could see a bullish makeover.
AUTHOR: Chaitali MohileDATE: APR 2011
ARTICLE SYNOPSIS...Statistical analysis is used to show that Pfizer is in the process of reversing its intermediate-term trend from up to down.
AUTHOR: Alan R. NorthamDATE: MAR 2012